# L'Oréal account plan

> L'Oréal is the world's No. 1 beauty company, with 40 international brands sold in 150+ countries and FY2025 sales of €44.05bn.

## At a glance

L'Oréal is a beauty company covering skincare, make-up, haircare, hair colour and perfumes across all channels and price points, sold in more than 150 countries through four Divisions: Consumer Products, L'Oréal Luxe, Dermatological Beauty and Professional Products. In FY2025 sales were €44.05bn (+4.0% like-for-like, +1.3% reported), operating profit €8,892m at a record 20.2% margin and EPS €12.71. The Group employs about 95,000 people and runs 37 factories and 160 distribution centres; e-commerce passed 30% of sales. It is listed, with the Bettencourt Meyers family holding 34.79% and Nestlé 20.16%; Jean-Paul Agon is Chairman and Nicolas Hieronimus CEO.

## Business units

- **Consumer Products** (€16,089.7m, 36.5% of FY2025 sales): Mass-market beauty built on L'Oréal Paris, Garnier, Maybelline New York and NYX Professional Makeup, plus regional brands such as 3CE, Mixa and Dr.G. It grew 3.5% like-for-like in 2025 with haircare the biggest contributor and +4.3% adjusted like-for-like in H1 2026. Led by Fabrice Megarbane from 1 January 2026.
- **L'Oréal Luxe** (€15,595.1m, 35.4% of FY2025 sales): Luxury beauty for the selective market (Lancôme, Yves Saint Laurent, Armani, Prada, Valentino, Aesop, Kiehl's and others), now including Kering Beauté (Creed, Bottega Veneta, Balenciaga) consolidated from April 2026. It grew 2.8% like-for-like in 2025 and +5.1% adjusted in H1 2026, with fragrances growing double digits. Led by Cyril Chapuy.
- **Dermatological Beauty** (€7,204.1m, 16.4% of FY2025 sales): Dermocosmetics recommended by healthcare professionals: La Roche-Posay, CeraVe, Vichy, SkinCeuticals and Skinbetter Science, the most profitable Division at a 26.1% margin. It grew 5.5% like-for-like in 2025 and accelerated to +10.6% adjusted in H1 2026 as CeraVe turned around. Led by Myriam Cohen-Welgryn.
- **Professional Products** (€5,163.0m, 11.7% of FY2025 sales): Professional haircare, hair colour and styling for salons and omnichannel distribution: Kérastase, L'Oréal Professionnel, Redken, Matrix and Color Wow. The fastest-growing Division at +7.5% like-for-like in 2025 and +11.6% adjusted in H1 2026. Led by Omar Hajeri.

## Strategic priorities

- **Multi-division category growth**: Capture growth in the traditional market and in adjacent territories through Universalisation and Singularisation, targeting Gen Z, the over-60s, men and body care.
- **Emerging markets and China**: Emerging markets are 17% of sales but delivered 40% of 2025 growth; SAPMENA-SSA grew +13.8% adjusted in H1 2026 and L'Oréal outperformed the China market nearly three-fold.
- **AI and Beauty Tech**: AI across consumers (Beauty Genius assistant), business lines and employees, with 65,000+ employees trained in GenAI and partnerships with NVIDIA and OpenAI; the goal is to raise the weight of new launches by 300 basis points.
- **Adjacencies: longevity and aesthetics**: Longevity is presented as "a new scientific and strategic frontier", alongside beauty supplements, smart devices and aesthetics through the 20% stake in Galderma.
- **E-commerce growth**: E-commerce passed 30% of sales in 2025, growing double digits and faster than the market; it is over 50% of North Asia sales.
- **One L'Oréal and the NEO IT transformation**: Six internal shared service centres, nine geographic clusters and the NEO information-systems project to standardise processes; the new US IT system went live on 8 June 2026.

## Latest results

In H1 2026 L'Oréal's sales reached €23,776m, up 5.8% reported and +6.8% like-for-like (+6.5% adjusted), with growth in every Division, Region and category; Kering Beauté added scope from April. Operating profit rose 6.8% to €5,063m, a record first-half margin of 21.3%, and EPS excluding non-recurring items was €7.40 (+4.8%). Professional Products (+11.6% adjusted) and Dermatological Beauty (+10.6%) led, while Luxe grew +5.1%, twice the selective market. Residual cash flow was -€9,773m after the Kering Beauté and Galderma deals. The CEO expects "another year of growth in sales and profit" in 2026.

## Investments and deals

- **Kering Beauté acquisition**: House of Creed plus 50-year Bottega Veneta, Balenciaga and Gucci beauty licences for €4bn, closed 31 March 2026 at a provisional price of €4,246.5m; the Gucci licence takes effect on 1 July 2027.
- **Galderma stake to 20%**: An additional 10% of Galderma bought for €4.2bn, closed 10 February 2026, with two L'Oréal nominees on its board.
- **Bolt-on brand acquisitions**: Dr.G, Medik8 and Color Wow in 2025 (€2.4bn cash out), a Jacquemus licence and minority stake, and a majority stake in India's Innovist signed in June 2026.
- **Capex and IT**: 2025 capex of €1,495m (3.4% of sales, 26% of it IT); Gauchy fragrance plant capacity doubled and a new US R&I Centre with 600+ scientists inaugurated.
- **Sustainable innovation funds**: L'AcceleratOR, a five-year €100m sustainable innovation accelerator, selected its first 13 start-ups in January 2026.

## Challenges and risks

- **Geopolitics and tariffs**: North America (26.6%) and North Asia (22.9%) of sales are exposed to tariffs and protectionism; Gulf consumption was hit by the Middle East conflict in 2026.
- **IT and cybersecurity during migration**: Information systems and cybersecurity risk is amplified by the IT transformation and by AI-enabled attacks.
- **US product liability litigation**: Product liability lawsuits cost €179m of charges in 2025 and €169m in H1 2026.
- **China and travel retail softness**: North Asia grew only +0.5% like-for-like in 2025, and Travel Retail remains affected by mainland China.
- **Supplier dependence**: Production purchases of €6.3bn (14% of sales) carry product-availability and supplier-concentration risk.

## What leadership says

> "if you stand still, you'll just be hit by the difficulties of the world" — Nicolas Hieronimus, CEO, WWD Beauty Inc profile (November 2025)

> "E-commerce is a key factor for us. It's 30% of our business now." — Nicolas Hieronimus, CEO, CNBC interview on FY2025 results (February 2026)

> "you must never forget that beauty is an offer market. People don't tell you what they need. You have to tell them, and that's why innovation is absolutely key." — Nicolas Hieronimus, CEO, Beauty x Medicine podcast with Galderma (February 2026)

> "our innovation engine is firing on all cylinders – and AI will help it maintain its pace" — Nicolas Hieronimus, CEO, Half-Year Financial Report at 30 June 2026 (July 2026)


## Where a supplier can help

- **IT migration and cybersecurity**: The NEO IT transformation and the cybersecurity risk it amplifies point to integration, testing and security partners.
- **AI for R&I, content and commerce**: The AI priority (predictive formulation, GenAI content, agentic commerce) opens room for AI tooling, data and content-production suppliers.
- **Integrating acquired brands**: Kering Beauté, Medik8, Color Wow, Dr.G and Innovist all need integration in supply chain, systems and go-to-market.
- **E-commerce and retail media**: E-commerce above 30% of sales and growing double digits calls for marketplace, retail-media and analytics partners.
- **Supply resilience**: Supplier concentration on €6.3bn of production purchases and capacity investments such as Gauchy create needs for packaging, ingredients and supply-chain services.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [2025 Universal Registration Document (including the Annual Financial Report, the Integrated Report and the Sustainability Report)](https://www.loreal-finance.com/system/files/2026-03/LOREAL_DEU_2025_EN.pdf)

Annual report · 2026-03-18

- L'Oréal is the world's No. 1 beauty company (2024 beauty sales USD 47.04bn vs Unilever 26.63bn and Estée Lauder 15.20bn), with 40 international brands sold in 150+ countries through four Divisions: Consumer Products (€16.1bn, 36.5% of sales), L'Oréal Luxe (€15.6bn, 35.4%), Dermatological Beauty (€7.2bn, 16.4%) and Professional Products (€5.2bn, 11.7%).
- FY2025 sales €44.05bn, +4.0% like-for-like but only +1.3% reported (currency -3.6%); operating profit €8,892m, a record 20.2% margin (+20bp); EPS €12.71 (+0.4%); dividend proposed €7.20 (+2.9%); operating cash flow €7.2bn (+7.8%); net debt down to €2.05bn (19% of EBITDA).
- Growth accelerated quarter after quarter: Professional Products +7.5% LFL (sales passed €5bn), Dermatological Beauty +5.5%, Consumer Products +3.5%, Luxe +2.8%; by region Europe +4.4%, North America +3.4%, North Asia +0.5%, SAPMENA-SSA +10.9%, Latin America +8.3%. Emerging markets are 17% of sales but delivered 40% of growth; e-commerce grew double digits and passed 30% of sales.
- Haircare (+12.9% LFL, €7.7bn) and perfumes (+10.4%, €6.4bn) were the growth categories; skincare (€16.4bn, +0.4%) and hair colourants were flat; makeup +3.5%.
- 2025 was a record M&A year: Dr.G, Medik8 and Color Wow acquired (€2.4bn cash out), Jacquemus licence plus minority stake, the €4bn Kering Beauté deal (Creed plus 50-year Bottega Veneta, Balenciaga and later Gucci licences) announced 19 October 2025 and expected to close in H1 2026, and the Galderma stake raised from 10% to 20% (closed 10 February 2026). €2.9bn of Sanofi shares were sold to help fund this.
- Strategy: a multi-division category model, Universalisation plus Singularisation, growth from emerging markets, Gen Z, over-60s, men and body care, and adjacencies (longevity, beauty supplements, smart devices, aesthetics via Galderma). R&I spend €1,381m (3.1% of sales), 725 patents filed (record), 22 research centres; 8,000+ in-house digital/tech/data experts; 65,000+ employees trained in GenAI; partnerships with NVIDIA and IBM.
- Operations: 37 factories, 160 distribution centres, 7bn+ products a year, €6.3bn of production purchases; capex €1,495m (3.4% of sales, 26% of it IT) as the NEO IT transformation and One L'Oréal shared service centres roll out; Gauchy fragrance plant capacity doubled.
- Top risks flagged: geopolitical/tariff exposure (North America 26.6% and North Asia 22.9% of sales), IT systems and cybersecurity during the IT migration, data, US product liability litigation (€179m of charges in 2025), product availability and supplier dependence, inflation and currency.
- Governance is stable: Bettencourt Meyers family 34.79%, Nestlé 20.16%; Jean-Paul Agon Chairman, Nicolas Hieronimus CEO (age 62); Executive Committee reshuffled on 1 January 2026 (Alexis Perakis-Valat to CEO L'Oréal USA, Fabrice Megarbane to Consumer Products, Emmanuel Goulin to Europe, Vianney Derville to Chief Growth Officer, Eva Yu to Travel Retail).
- 2026 outlook (CEO): optimistic on the beauty market despite macro uncertainty, confident of outperforming it and of another year of growth in sales and profit; “L'Oréal is entering 2026 stronger than ever.”

### [Half-Year Financial Report at 30 June 2026](https://www.loreal-finance.com/system/files/2026-07/LOREAL_RFS_2026_UK.pdf)

Interim report · 2026-07-31

- H1 2026 sales €23,776m, +5.8% reported, +6.8% like-for-like and +6.5% adjusted like-for-like (stripping out IT-migration phasing); scope +1.8% (Kering Beauté consolidated from April), currency -2.8%. Growth in every Division, Region and category.
- Operating profit €5,063m (+6.8%), a record first-half margin of 21.3% (+20bp); gross margin 74.8%; advertising and promotion raised 70bp to 32.6% of sales while SG&A fell 70bp. EPS excluding non-recurring items €7.40 (+4.8%); net profit €3,547m.
- Divisions (adjusted LFL): Professional Products +11.6% (margin 23.3%), Dermatological Beauty +10.6% (margin 28.4%, third consecutive quarter of acceleration; La Roche-Posay, CeraVe and SkinCeuticals all double digits), Luxe +5.1% (twice the selective market; fragrances double digits; YSL Libre now the world's No. 1 women's fragrance), Consumer Products +4.3% (L'Oréal Paris double digits in the US).
- Regions (adjusted LFL): SAPMENA-SSA +13.8%, North America +6.7% (new IT system live in the US on 8 June), Europe +6.1%, Latin America +5.2%, North Asia +4.6% (L'Oréal outperformed the China market nearly three-fold; e-commerce over 50% of North Asia sales). Gulf consumption hit by the Middle East conflict except Saudi Arabia.
- Kering Beauté closed 31 March 2026 for an acquisition price of €4,246.5m (goodwill €2,840.9m; Creed brand valued €857.2m); a 50-year Gucci beauty licence signed in July, effective 1 July 2027, after Coty's early exit (cost around USD 360m). Galderma stake raised to 20% on 10 February 2026 for €4.2bn. Majority stake in India's Innovist (Bare Anatomy, Chemist at Play) signed in June.
- Cash: operating net cash flow €3,122m (+13.9%), but residual cash flow -€9,773m after €4,029.9m of acquisitions and €4,224.1m of financial investments; borrowings rose to €14,337.3m, cash €4,048.8m; CHF 500m bond issued; €501m buyback.
- Partnerships announced: Institut Pasteur (skin science), NVIDIA ALCHEMI (AI computational chemistry), OpenAI (agentic commerce and AI-powered métiers). Fund for Women renewed with €50m for 2026-2030, Climate Emergency Fund +€20m.
- CEO outlook: demand for beauty “remains strong”; confident of continuing to outperform the market and of “another year of growth in sales and profit” in 2026, with AI helping the innovation engine keep its pace.

### [How L'Oréal CEO Nicolas Hieronimus Is Propelling the Company Forward (WWD Beauty Inc, Pete Born Impact Award profile)](https://wwd.com/beauty-industry-news/beauty-features/loreal-ceo-nicolas-hieronimus-is-propelling-the-company-forward-1238336114/)

Executive talk · Nicolas Hieronimus, Chief Executive Officer, L'Oréal Groupe · 2025-11-18

- Long WWD profile built on an interview at L'Oréal's Clichy headquarters one week after the Kering Beauté announcement (a €4bn deal, the largest in L'Oréal's history) and the day after Q3 2025 sales (+4.2% like-for-like, a slight miss).
- Hieronimus' philosophy against inertia: “if you stand still, you'll just be hit by the difficulties of the world”; the answer is to keep acquiring and venturing into new territories.
- M&A is the growth engine: CeraVe was a €140m brand at acquisition in 2017 and now exceeds €2bn (No. 5 skincare brand in the world); selectivity matters because “there's not one week when I don't have a proposition to acquire” an indie brand; Medik8 and Color Wow were chosen for their technology, not influencer buzz.
- Kering Beauté gives L'Oréal entry into high-end niche fragrance (Creed), where it is under-penetrated, and reinforces designer licences; Gucci beauty (under USD 1bn at Coty) is seen as a brand that “will explode again” given L'Oréal's track record with Armani and YSL.
- Portfolio moves under his tenure: Youth to the People, Skinbetter Science, Dr.G, Aesop, Medik8, Color Wow, Kering Beauté; licences with Jacquemus and Miu Miu; minority stakes in Amouage, Shinehigh Innovation and Galderma (10% in 2024); the Circular Innovation, Climate Emergency and Solstice funds; BOLD accelerated.
- Organisation: North Asia/China decoupled from the rest of Asia and a SAPMENA-SSA region created for emerging markets (almost €3.9bn in 2024, about 9% of sales, growing 12.3%).
- AI is “the big game changer”: augmenting molecule and formula creation and marketing content, to help raise the weight of new launches by 300 basis points; innovation is managed “in a double time frame” (breakthroughs like Melasyl plus fast reactive launches).
- Agon's view of his legacy: turning L'Oréal into a “beauty tech” company; Hieronimus will be 62 in January 2026 and is expected to serve until 65.

### [L'Oréal CEO Nicolas Hieronimus on Why Beauty Is More Important Now Than Ever (WWD Beauty Inc Awards fireside chat)](https://wwd.com/beauty-industry-news/beauty-features/loreal-ceo-nicolas-hieronimus-beauty-industry-luxury-1238363024/)

Executive talk · Nicolas Hieronimus, Chief Executive Officer, L'Oréal Groupe · 2025-12-02

- Fireside chat with Beauty Inc editor in chief Jenny B. Fine at the 2025 WWD Beauty Inc Awards, where Hieronimus received the Pete Born Impact Award.
- Core thesis: “Beauty is more important than ever… it's one of the few categories that systematically grows, at the global level, higher than the GDP”, and “You cannot stand still in beauty.”
- Acquisitions as learning: “sometimes you have to know what you don't know; making acquisitions through BOLD is a way for us to learn and to grow” (recent investments: Omani fragrance house Amouage, Chinese clean skincare brand Lan); BOLD has shifted from investing in brands to investing in technologies (e.g. Gjosa's water-saving shower head, -60% water).
- Luxury: L'Oréal became the world's No. 1 luxury beauty player about two years ago and the Kering Beauté acquisition will “broaden that lead” – “I love to race in front.”
- China: “a major growth engine for more than a decade; it has stabilized, and I think it will start growing again”; L'Oréal Paris kept the No. 1 spot on Double 11 in 2025 with several other brands in the top 10.
- Emerging markets need local understanding (Saudi Arabia's appetite for fragrance, South Africa's haircare boom), hence labs in different parts of the world.
- Scale with agility: “People see us as the behemoth, and there is indeed a benefit to scale, but it has to come with agility.”

### [L'Oréal CEO talks M&A, e-commerce and growth plans in exclusive interview (CNBC, full-year 2025 results)](https://www.youtube.com/watch?v=0jIhJg6b3fI)

Video · Nicolas Hieronimus, Chief Executive Officer, L'Oréal Groupe · 2026-02-13

- CNBC segment with Charlotte Reed on the day of L'Oréal's FY2025 results: full-year sales €44bn, +4% like-for-like; Q4 revenue up 6% to more than €11bn; North America +8.6% like-for-like in Q4 and Europe +6.6%, but North Asia only +0.6% in Q4 (+0.5% for the year), about 5 points below analyst expectations, so the shares fell.
- Hieronimus calls 2025 “a very defining year”: resilience in a volatile environment (tariffs, geopolitical tensions, changing consumer mindset), growth above the market and acceleration quarter after quarter, and heavy investment in transformation “both on the tech side in IT but also in M&A” with the Kering Beauté acquisition.
- The two biggest countries accelerated in H2: China went from about +1% to +5% between H1 and H2 (“a modest acceleration but we've outperformed it”), mostly a Luxe story; the US went from about +2% to +4%, driven by the mass-market and Dermatological Beauty divisions.
- E-commerce is now 30% of the business, growing double digits and faster than the market: “that's really where most of the market growth comes from.”
- The H1 2025 weak spots were mass-market (too dependent on makeup) and Dermatological Beauty (lacking innovation); the “beauty stimulus plan” that stepped up innovation across all divisions, fragrance included, drove the H2 acceleration and “makes me ambitious for 2026”.
- Intends to keep the Q4 North American momentum and to accelerate again in 2026; CNBC notes the Kering Beauté brands (Creed, Balenciaga, Bottega Veneta, later Gucci) and the Galderma stake raised to 20% as growth avenues.

### [Beauty x Medicine, Season 2 opener: Galderma CEO Flemming Ørnskov in conversation with Nicolas Hieronimus, CEO of L'Oréal](https://www.youtube.com/watch?v=ksU_iRYbM-o)

Podcast · Nicolas Hieronimus, Chief Executive Officer, L'Oréal Groupe · 2026-02-27

- 15-minute episode of Galderma's podcast and video series, recorded after L'Oréal raised its Galderma stake; host Flemming Ørnskov recalls L'Oréal was a founding partner of Galderma in 1981 with Nestlé.
- Hieronimus on his five years as CEO: keeping L'Oréal on course “from COVID to inflation, to wars, to tariffs”, with resilient top-line growth faster than the beauty market and improving profitability, while preparing the future through acquisitions (Dr.G, Color Wow, Medik8, Kering Beauté, “the biggest acquisition of the group's history”) and the Galderma participation, “a very important adjacent territory in beauty”.
- Longevity is “probably the number one buzzword” in skincare: consumers are moving “from correcting aging to reprogramming aging”, combining skincare, UV protection, supplements, diet, sport, wearables and aesthetic procedures into protocols – “a very, very deep trend across the world”.
- US and China: beauty consumption improving in both; China picked up in Q4 with a more pragmatic consumer seeking value and quality (SkinCeuticals “doing phenomenal in China”), the US resilient and accelerating through 2025; beauty is “a refuge category” – the fourth largest US spending category after mortgage, food and gas.
- “Beauty is an offer market. People don't tell you what they need. You have to tell them,” hence innovation: R&I is over 3% of turnover, €1.3bn.
- Beauty Tech (devices, diagnostics, AI-powered recommendations, virtual try-ons): L'Oréal claims the No. 1 position; it was the first beauty company at CES (2015) and gave the CES keynote in 2024.
- Aesthetics and skincare are synergistic: women who do procedures spend two times more on creams and beauty products than the average; SkinCeuticals and Skinbetter Science learn from dermatologists; a joint research partnership on imaging is under way.
- Staying No. 1: innovation (“new molecules, new formulas”), scientific partnerships, and a competitive, passionate culture – “you're never complacent”.

## Questions about L'Oréal

### What does L'Oréal do?

L'Oréal makes and sells beauty products across skincare, make-up, haircare, hair colour and perfumes, through four Divisions and in more than 150 countries.

### What is L'Oréal's revenue?

FY2025 sales were €44.05bn, +4.0% like-for-like, with operating profit of €8,892m. H1 2026 sales were €23,776m.

### How many employees does L'Oréal have?

The Group employs about 95,000 people.

### What is L'Oréal's strategy?

A multi-division category strategy that targets emerging markets, e-commerce and new consumer groups, adds adjacencies such as longevity and aesthetics, and invests in AI and acquisitions.

### Who leads L'Oréal?

Nicolas Hieronimus is CEO and Jean-Paul Agon is Chairman; Christophe Babule is CFO.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
